11:43 AM EST - Aequus Pharmaceuticals Inc. : Has entered into an agreement with a syndicate of agents led by Cormark Securities Inc. and including Canaccord Genuity Corp. on best efforts agency basis, to sell a minimum of 6,667,000 common shares and a maximum of 13,340,000 Shares from the treasury of the Company, at a price of $0.30 per Share for aggregate gross proceeds of approximately $2.0 million, in the case of the minimum offering, and approximately $4.0 million, in the case of the maximum offering. Aequus Pharmaceuticals Inc.
shares V.AQS are trading down $0.02 at $0.31.
